Search

Gossamer Bio Inc

Lezárt

SzektorEgészségügy

9.17 -6.62

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

9.17

Maximum

9.65

Fő mutatók

By Trading Economics

Bevétel

64M

17M

Értékesítés

-7.7M

9.2M

Egy részvényre jutó nyereség

-0.2

Profit margin

182.94

Munkavállalók

161

EBITDA

-28M

-71M

Ajánlások

By TipRanks

Ajánlások

Semleges

12 hónapos előrejelzés

+631.47% upside

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

65M

Előző nyitás

15.79

Előző zárás

9.17

Gossamer Bio Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. okt. 9. 19:55 UTC

Gossamer Bio Inc shares fell sharply, continuing a notable decline since Thursday's close and remaining well below the 20-day moving average.

2026. okt. 8. 23:15 UTC

Gossamer Bio Inc shares advanced in after-market trading following Thursday's close, although they remain significantly below their 20-day moving average.

2026. okt. 7. 22:01 UTC

Gossamer Bio Inc is advancing in after-market trading, gaining notable ground since Wednesday's close despite being below its 20-day moving average.

2026. okt. 6. 19:45 UTC

Gossamer Bio Inc shares are higher today, having advanced since Monday's close, though they remain below their 20-day moving average.

2026. okt. 5. 22:01 UTC

Gossamer Bio Inc saw a significant rally in after-market trading, recovering from previous dips and closing above its 20-day moving average.

2026. okt. 2. 22:20 UTC

Gossamer Bio Inc is trading lower in after-hours, continuing a downward trend amid broader market declines, with three consecutive sessions finishing lower.

2026. okt. 1. 20:06 UTC

Gossamer Bio Inc shares fell sharply, reversing an early uptick and continuing to decline, remaining well below their 20-day moving average.

2026. szept. 28. 20:07 UTC

Gossamer Bio Inc is sharply higher, recovering notably since Friday's close, despite remaining below its 20-day moving average and near its one-month range low.

2026. szept. 25. 20:12 UTC

Gossamer Bio Inc declined sharply in after-market hours, marking a fifth consecutive session lower and remaining significantly below its 20-day moving average.

2026. szept. 24. 19:35 UTC

News
Social Media

Gossamer Bio Inc shares fell sharply after reaching a session high, despite submitting a New Drug Application for seralutinib to treat pulmonary arterial hypertension.

2026. szept. 23. 23:15 UTC

Social Media
News

Gossamer Bio Inc has submitted a New Drug Application for seralutinib targeting pulmonary arterial hypertension, with shares advancing in after-market trading.

2026. szept. 22. 19:45 UTC

Gossamer Bio Inc is experiencing a sharp increase in its stock price, reaching a peak cumulative return before settling at a notable gain.

2026. szept. 21. 21:41 UTC

Gossamer Bio Inc is rising in after-market trading, gaining ground since Monday's close, despite remaining below its 20-day moving average.

2026. szept. 18. 22:11 UTC

Gossamer Bio Inc has rallied sharply in after-market trading, rebounding from earlier losses and advancing significantly since Friday's close.

2026. szept. 17. 20:07 UTC

News

Gossamer Bio Inc. shares are sharply higher as the company appointed Greg Ciongoli to its Board of Directors, effective September 16, 2026.

2026. szept. 16. 20:10 UTC

Gossamer Bio Inc's stock price is sharply higher in Wednesday's trading session, recovering from an initial dip to peak above Tuesday's close.

2026. szept. 15. 21:05 UTC

Gossamer Bio Inc. shares traded lower in after-market hours, remaining below the 20-day moving average and near the lower end of their one-month range.

2026. szept. 14. 20:07 UTC

Gossamer Bio Inc. shares are higher today amid broader market dynamics, despite ongoing concerns about rising crude oil prices and their inflationary effects.

2026. szept. 11. 23:01 UTC

Gossamer Bio Inc. shares are higher in after-hours trading, reflecting a notable increase since Friday's close amid positive market sentiment following a narrower U.S. budget deficit.

2026. szept. 10. 23:31 UTC

Event

Gossamer Bio Inc. shares rose in after-market trading following a 1-for-80 reverse stock split, advancing from earlier levels despite broader market dynamics.

2026. szept. 9. 23:53 UTC

Gossamer Bio Inc. shares are lower in after-market hours following a significant decline since Wednesday's close, despite an earlier attempt to recover.

2026. szept. 4. 19:26 UTC

Gossamer Bio shares are lower today amid increased selling pressure on risk assets, influenced by strong jobs data and rising interest rate expectations.

2026. szept. 3. 23:26 UTC

Gossamer Bio Inc shares are lower in after-market hours, with no specific news identified for the decline. Major indices rose amid reduced interest rate hike expectations.

2026. szept. 2. 23:06 UTC

Gossamer Bio Inc. shares are higher in after-market trading, remaining above their 20-day moving average and within the one-month trading range.

2026. szept. 1. 23:06 UTC

Gossamer Bio Inc. shares declined in after-market trading, influenced by rising oil prices and inflation concerns amid a broader performance below the 20-day moving average.

2026. aug. 31. 20:07 UTC

Gossamer Bio Inc is higher today amid broader market reactions to potential Federal Reserve interest rate hikes following remarks from Warsh at the Jackson Hole symposium.

2026. aug. 28. 23:06 UTC

Gossamer Bio Inc. shares are higher in after-market trading, reflecting positive momentum since Friday's close amid broader market volatility.

2026. aug. 27. 23:01 UTC

News

Gossamer Bio announced a private placement that could yield up to $250 million, with an initial $25 million expected upfront. Shares are roughly flat in after-market hours.

2026. aug. 26. 23:01 UTC

Gossamer Bio Inc is higher in after-market trading, reflecting broader market gains amid positive economic data on personal consumption and durable goods orders.

2026. aug. 25. 23:01 UTC

Gossamer Bio shares were lower in after-market hours, with no specific news identified. The broader market retreated after an initial advance amid falling crude oil prices.

Társak összehasonlítása

Árváltozás

Gossamer Bio Inc Előrejelzés

Célár

By TipRanks

631.47% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 68.1 USD  631.47%

Magas 90 USD

Alacsony 22.4 USD

5 Wall Street elemző 12 hónapos célárain alapulva a(z)Gossamer Bio Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Semleges

5 ratings

2

Vétel

2

Tartás

1

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$